The AACR Cancer Disparities Progress Report 2026 is available. The report provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Read The Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreIn the US, the overall cancer death rate is declining steadily thanks to advances in cancer treatment propelled by breakthroughs across the continuum of cancer science.
Read the ReportMore than 42,000 adults in the United States are expected to be diagnosed with liver cancer this year. October is Liver Cancer Awareness Month. Read about the prevention, screening, and treatment options for this disease.
Learn MoreAACR Project GENIE is a publicly accessible international cancer registry of real-world data assembled through data sharing between many of the leading cancer centers in the world.
Learn MoreInvesting in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Read MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe Call for Abstracts for the AACR Annual Meeting 2027 (April 2-7) is now available. Abstract Deadline: November 10
The AACR Cancer Progress Report 2026 highlights the remarkable progress against cancers driven by discoveries across basic, translational, clinical, and population science.
Learn MoreThe AACR and its more than 65,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2024
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2025, to June 30, 2026
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More